HuCAL

Type: Product
Name: HuCAL
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

MorphoSys to Receive Milestone Payment for Guselkumab Phase 3 Program

Details Category: Antibodies Published on Thursday, 23 October 2014 07:19 Hits: 41MARTINSRIED/MUNICH, Germany I October 22, 2014 I MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that its collaborator Janssen Biotech, ... [Published PipelineReview - Oct 23 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

MorphoSys receives clinical milestone in ophthalmology programme from Novartis

MorphoSys AG has received a milestone payment from Novartis in connection with the initiation of a phase 1 clinical trial of a HuCAL antibody in the field of diabetic eye diseases. This becomes the ninth therapeutic antibody made using MorphoSys's technologies ... [Published PharmaBiz - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 3 reports

MorphoSys Announces Clinical Milestone in Ophthalmology Program

Details Category: Antibodies Published on Monday, 20 October 2014 08:57 Hits: 28MARTINSRIED/MUNICH, Germany I October 20, 2014 I MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has received a milestone payment ... [Published PipelineReview - Oct 20 2014]
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

MorphoSys buys Lanthio Pharma's lanthipeptide technology

MorphoSys AG, a leading biotechnology companies focusing on fully human antibodies, and Lanthio Pharma, a privately held drug discovery company, announced the acquisition of Lanthio Pharma's lanthipeptide technology, which will be used for drug discovery ... [Published PharmaBiz - Oct 17 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 2 reports

MorphoSys Acquires Lanthipeptide Technology from Lanthio Pharma

MARTINSRIED/MUNICH, Germany, Oct. 15, 2014 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and Lanthio Pharma today announced the acquisition of Lanthio Pharma's lanthipeptide technology, which will be used for ... [Published Virtual Strategy Magazine - Oct 15 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

September albums of the month: Slow Magic’s ‘How to Run Away’

By Anneliese HucalOne of electronic dance music’s Achilles’ heels is its tendency to bombard listeners with immature and repetitive lyrics ridden with painfully predictable phrases that tend to infest club dance floors.The selling point of up-and-coming ... [Published Nevada Sagebrush - Sep 30 2014]
Entities: HuCAL, Atmosphere, Manhattan
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Polish banking, energy and public services weigh up benefits of big data applications

For companies and institutions in Poland, big data is primarily a buzzword, a topic of discussion and in the sphere of planning. But banks have gone a stage further in starting to use big data technologies.Some 36% of companies in Poland believe the analysis ... [Published Computer Weekly - Sep 25 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

MorphoSys Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs

MorphoSys AG / . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today the receipt of a grant ... [Published PR inside - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

A clean vagina is a happy vagina: tips from a sex columnist

About 2 years ago I stumbled upon a Tumblr page that specialized in documenting and praising the unique shapes and forms of vaginas from all across the world. It aimed to spread awareness, but it also made me realize something. As I perused the page of ... [Published Nevada Sagebrush - Sep 23 2014]
Entities: Vagina, Bacteria, Sex, Infectious
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Celibate sisters: looking to your sorority for support

T his is a love letter to Greek letters, but it will not mention bid-day, parties, philanthropy or awards. It is not going to tell you to go through recruitment or which fraternities have the hottest men or which stereotypes are true. This is a story ... [Published Nevada Sagebrush - Sep 16 2014]
Entities: Recruitment, Sex, HuCAL
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Monoclonal antibodies against ANGPTL3

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are ... [Published PharmCast - Jun 17 2014]

Quotes

"Our therapeutic antibody pipeline represents the main value driver for MorphoSys and we are delighted to see our third HuCAL antibody advancing into late-stage clinical development. With every phase 3 start, the time when the first HuCAL antibody drug could enter the market gets closer" commented Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG
...with Novartis moving into the clinic in the months and years ahead," commented Marlies Sproll, chief scientific officer of MorphoSys, adding: "We are also very pleased that this is the third ophthalmology program within our collaboration to enter the clinical development stage."
Dr. Gert Moll, chief scientific officer of Lanthio Pharma commented: "Great synergies between our companies have resulted in a very successful collaboration. We are confident that MorphoSys will be able to further exploit the great potential of our technology platform by bringing more lanthipeptide drugs into the clinic."
"He did it by accepting the rules of services provided. It is worth reading such documents.”"

More Content

All (20) | News (17) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
MorphoSys to Receive Milestone Payment for Guse... [Published PipelineReview - Oct 23 2014]
MorphoSys to Receive Milestone Payment for Guse... [Published GlobeNewswire: Acquisitions News - Oct 22 2014]
MorphoSys to Receive Milestone Payment for Guse... [Published Value Investing News - Oct 22 2014]
MorphoSys gets milestone from Novartis; acquire... [Published Pharma Letter - Oct 21 2014]
MorphoSys receives clinical milestone in ophtha... [Published PharmaBiz - Oct 21 2014]
MorphoSys Announces Clinical Milestone in Ophth... [Published PipelineReview - Oct 20 2014]
MorphoSys Announces Clinical Milestone in Ophth... [Published GlobeNewswire: Acquisitions News - Oct 20 2014]
MorphoSys Receives Milestone Payment From Novar... [Published RTTNews.com - Oct 20 2014]
MorphoSys Announces Clinical Milestone in Ophth... [Published Value Investing News - Oct 20 2014]
MorphoSys buys Lanthio Pharma's lanthipeptide t... [Published PharmaBiz - Oct 17 2014]
MorphoSys Acquires Lanthipeptide Technology fro... [Published Virtual Strategy Magazine - Oct 15 2014]
MorphoSys Acquires Lanthipeptide Technology fro... [Published Indianapolis Business Journal - Oct 15 2014]
September albums of the month: Slow Magic’s ‘Ho... [Published Nevada Sagebrush - Sep 30 2014]
Polish banking, energy and public services weig... [Published Computer Weekly - Sep 25 2014]
MorphoSys Receives Research Grant to Develop No... [Published PR inside - Sep 23 2014]
A clean vagina is a happy vagina: tips from a s... [Published Nevada Sagebrush - Sep 23 2014]
Celibate sisters: looking to your sorority for ... [Published Nevada Sagebrush - Sep 16 2014]
MorphoSys AG Reports Results for the First Six ... [Published GlobeNewswire: Advertising News - Jul 28 2014]
Monoclonal antibodies against ANGPTL3 [Published PharmCast - Jun 17 2014]
MorphoSys gets clinical milestone from Novartis... [Published PharmaBiz - Feb 18 2014]
1
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
MorphoSys to Receive Milestone Payment for Guse... [Published GlobeNewswire: Acquisitions News - Oct 22 2014]
MorphoSys Announces Clinical Milestone in Ophth... [Published GlobeNewswire: Acquisitions News - Oct 20 2014]
MorphoSys AG Reports Results for the First Six ... [Published GlobeNewswire: Advertising News - Jul 28 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.